Litcius/Paper detail

Improved pulmonary function and exercise tolerance despite persistent pulmonary fibrosis over 1 year after severe COVID-19 infection

Claire McGroder, Mary Salvatore, Belinda D’Souza, Eric A. Hoffman, Matthew R. Baldwin, Christine Kim Garcia

2024Thorax12 citationsDOIOpen Access PDF

Abstract

We conducted a prospective single-centre cohort study of 104 multi-ethnic severe COVID-19 survivors from the first wave of the pandemic 15 months after hospitalisation. Of those who were assessed at 4 and 15 months, improvement of ground glass opacities correlated with worsened fibrotic reticulations. Despite a high prevalence of fibrotic patterns (64%), pulmonary function, grip strength, 6 min walk distance and frailty normalised. Overall, dyspnoea, cough and exhaustion did not improve and were not correlated with pulmonary function or radiographic fibrosis at 15 months, suggesting non-respiratory aetiologies. Monitoring persistent, and often subclinical, fibrotic interstitial abnormalities will be needed to determine their potential for future progression.

Topics & Concepts

MedicineSubclinical infectionPulmonary function testingPulmonary fibrosisCoronavirus disease 2019 (COVID-19)Internal medicineProspective cohort studyCohortFibrosisCystic fibrosisCohort studyDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesCOVID-19 and Mental Health